cas 151521-49-2|| where to buy 4-Isopropyl-1H-pyrazol-3-amine

Nom du produit:4-Isopropyl-1H-pyrazol-3-amine

IUPAC Name:4-(propan-2-yl)-1H-pyrazol-5-amine

Unité d'emballage	Stock disponible	Prix($)
CM188981-1g	in stock	ǆǠ
CM188981-5g	in stock	ſƤƋ
CM188981-25g	in stock	ȌȌɐƤ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 151521-49-2 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:151521-49-2; Formule moléculaire:C6H11N3; Point de fusion:-; Code SMILES:NC1=C(C(C)C)C=NN1; Densité:

: Numéro de catalogue:CM188981; Poids moléculaire:125.18; Point d'ébullition:295.8°C at 760 mmHg; N° Mdl:MFCD11112127; Stockage:Store at 2-8°C.

: Pyrazoles; Pyrazoles are organic compounds of the general formula C3H3N2H. It is a five-membered heterocycle consisting of three carbon atoms and two adjacent nitrogen atoms. As an H-bond-donating heterocycle, pyrazole has been used as a more lipophilic and metabolically more stable bioisomer of phenol. Pyrazoles have attracted more and more attention due to their broad spectrum of action and strong efficacy.; Pyrazone; Custom pyrazone for customers from all over the world are our main business.

: Samuraciclib; Carrick Therapeutics’ Phase 2 Clinical Trial of Samuraciclib combined with Fulvestrant has dosed its first patient. The study targets patients with CDK4/6i resistant HR+, HER2- metastatic breast cancer. Samuraciclib is a selective oral, first-in-class inhibitor of CDK7. It is involved in the regulation of cancer-causing genes, promotion of uncontrolled cell cycle progression, and increase in resistance to anti-hormone therapy. The comb previously receives the Fast Track Designation from the U.S. FDA.